Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

NHS Becomes First In Europe To Offer This Revolutionary Treatment

The NHS has become the first healthcare system in Europe to widely roll out a revolutionary take home tablet for multiple sclerosis patients that requires just 20 days of treatment spread over four years. Cladribine offers a life changing alternative to existing therapies that involve regular hospital infusions, frequent self injections, and extensive monitoring that keep patients tethered to medical facilities. Approved by NICE for patients with active relapsing remitting MS, the convenient tablet provides comparable clinical benefits while dramatically reducing hospital visits and freeing patients to live their lives with greater independence.

Nearly 80 percent of patients taking cladribine experienced no relapses during clinical trials, which also revealed a stunning reduction of 7.5 times fewer new brain lesions compared to those on placebo. The treatment is especially beneficial for patients planning families, as its short course regimen over two years allows safe conception in years three and four of the treatment cycle. An estimated 2,000 patients will be offered this groundbreaking treatment over the first three years, saving thousands of clinical hours annually while improving quality of life for people living with MS. This rollout demonstrates the NHS’s commitment to adopting innovative treatments that shift care out of hospitals and into communities, giving patients more freedom while maximizing healthcare productivity.

PrevPreviousFighting Tumors With Covid Shots
NextOne Step Closer To Reversing BlindnessNext

Recent Articles

Happy News

One Step Closer To Reversing Blindness

October 31, 2025

Geographic atrophy affects nearly five million people worldwide and represents one of the most devastating forms of blindness, gradually destroying light-sensitive cells until patients can no longer read, drive, or recognize faces. An international team of scientists has achieved what many considered impossible by successfully restoring reading level vision to

Read More
Happy News

NHS Becomes First In Europe To Offer This Revolutionary Treatment

October 31, 2025

The NHS has become the first healthcare system in Europe to widely roll out a revolutionary take home tablet for multiple sclerosis patients that requires just 20 days of treatment spread over four years. Cladribine offers a life changing alternative to existing therapies that involve regular hospital infusions, frequent self

Read More
Happy News

Fighting Tumors With Covid Shots

October 31, 2025

Researchers at MD Anderson Cancer Center and the University of Florida have discovered something extraordinary about Pfizer and Moderna COVID vaccines that has nothing to do with preventing virus infections. Cancer patients with advanced lung or skin cancer who received these specific mRNA shots within 100 days of starting immunotherapy

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2025 HappyNews.